Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
Gabriela S.M. de Siqueira, Samir A. Hanna, Larissa F. de Moura, Fabiana Accioli Miranda, Heloísa de Andrade Carvalho, Gustavo Nader Marta DOI: https://doi.org/10.1016/j.lana.2022.100323 Full link: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00140-5/fulltext
Implications of the PEARL trial from the low- to middle-income countries’ perspectives
Tomás Reinert, Aline C Gonçalves, C A A de Resende, Carlos H Barrios DOI: DOI: 10.1016/j.ejca.2022.06.016 Full link: https://linkinghub.elsevier.com/retrieve/pii/S0959804922003677
Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: A descriptive-interpretative qualitative study
Carlos Barrios, Guillermo Sánchez-Vanegas, Cynthia Villarreal-Garza, Andrés Ossa, Milton A Lombana, Angélica Monterrosa-Blanco, Ana S Ferrigno, Carlos Alberto Castro DOI: 10.1016/j.lana.2022.100254 Full link: https://pubmed.ncbi.nlm.nih.gov/36778924/
Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
Andre G Gouveia, Fabio Y Moraes, Renato P Lima, Gustavo A Viani DOI: 10.5603/RPOR.a2022.0070 Full link: https://journals.viamedica.pl/rpor/article/view/90772
Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
Andre G Gouveia, Fabio Y Moraes, Renato P Lima, Gustavo A Viani DOI: 10.5603/RPOR.a2022.0070 Full link: https://journals.viamedica.pl/rpor/article/view/90772
Clinicopathological characterization, FGFR alteration prevalence, and outcomes of locally advanced or metastatic urothelial cancer in Latin America (LACOG 1518).
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
International Diploma in Molecular Biology Applied to Clinical Oncology (Fifth edition 2022)
The main objective of the International Diploma in Molecular Biology Applied to Clinical Oncology is to provide an excellence international educational program with high academic and professional European experts in the different oncological areas for the diagnosis and treatment of cancer-based on molecular biology. Each year, the program provides an invaluable opportunity to participate in the program. Each Fellowship is a stimulating challenge for talented young oncologists or in related areas who seek leading careers in oncology areas in public institutions. Download the Complete Program Diploma here Visit the webpage
Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil
Marcelo Langer Wroclawski, Breno Santos Amaral, Paulo Priante Kayano, Wilson Francisco Schreiner Busato Jr, Sebastião José Westphal, Erik Montagna, Bianca Bianco, Andrey Soares, Fernando Cotait Maluf, Gustavo Caserta Lemos, Arie Carneiro DOI: 10.1186/s12894-022-01036-1 Full link: https://bmcurol.biomedcentral.com/articles/10.1186/s12894-022-01036-1